When we adjusted our analyses for omentin-1 levels, a surrogate marker of visceral obesity, the comparison between healthy controls and patients with benign tumors failed to reach significance while comparison with cancer patients was persistent, suggesting that the association between irisin concentration and presence of breast malignancy is not affected by visceral adiposity. This evidence concerns the gene FNDC5 and cancer.